Clinical Experience with a Novel Intracoronary Perfusion Catheter to Treat No-Reflow Phenomenon in Acute Coronary Syndromes
Conclusion:The infusion of intracoronary drugs using the novel perfusion CW RX catheter seems to be safe and could help to improve myocardial perfusion in a selected group of patients presenting with ACS who developed no-reflow during PCI. (J Interven Cardiol 2010;**:1[ndash]5) (Source: Journal of Interventional Cardiology)...
POSTED 03/11/2010 at 06:00 PM --
|
Percutaneous Mechanical Assistance for the Failing Heart
One of the most challenging situations in contemporary medicine is, doubtlessly, the approach and treatment of patients presenting with severe left ventricle failure. Since its first clinical application in patients with cardiogenic shock in 1968, the intraaortic balloon pump (IABP) has been widely accepted by heart failure physicians. Although IABP therapy has been shown to be effective for the support and stabilization of hemodynamically compromised patients, it has failed to promote any improvements in patient outcomes. For this reason, much attention has been invested in the development of external devices that can collaborate with the treatment of this condition. In this context, the percutaneous left ventricle assist device (pLVAD), like TandemHeart (Cardiac Assist, Inc.; Pittsburgh,......
POSTED 03/11/2010 at 06:00 PM --
|
Relation of Multivessel Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction to Outcome and/or Non-Infarct Artery Intervention of a Chronic Total Occlusion
We read with interest the recent report by Cavender et al, questioning the guidelines and use of multivessel percutaneous coronary intervention (PCI) in the setting of ST elevation myocardial infarction (STEMI). The investigators concluded that multivessel primary PCI for STEMI does not improve in-hospital outcomes, even in patients with cardiogenic shock. (Source: The American Journal of Cardiology)...
POSTED 03/09/2010 at 07:57 AM --
|
Norepinephrine and Dopamine Treatment for Shock Compared
in patients with shock, treatment with dopamine and norepinephrine results in similar overall death
rates, but dopamine causes more adverse events and may pose a safety risk for patients in cardiogenic shock,
according to a study in the March 4 issue of the New England Journal of Medicine. (Source: Modern Medicine)...
POSTED 03/02/2010 at 06:00 PM --
|
Successful management of fulminant myocarditis with left ventricular assist device: report of a severe case.
We report a 65-year-old man with fulminant myocarditis undergoing percutaneous cardiopulmonary support (PCPS) and left ventricular assist device (LVAD). PCPS and intra-aortic balloon pumping was initially introduced for cardiogenic shock in the emergency department. We switched to LVAD because cardiac function did not recover despite PCPS for 5 days. Cardiac function then gradually improved, and the device was successfully weaned after 11 days of the LVAD support. He was discharged on postoperative day 63 with no complications. We here report the appropriate timing of LVAD application for fulminant myocarditis. (Ann Thorac Cardiovasc Surg 2010; 16: 48-51).
PMID: 20190711 [PubMed - in process] (Source: Annals of Thoracic and Cardiovascular Surgery)...
POSTED 03/02/2010 at 01:36 PM --
|
Successful recovery using surgical intervention to treat ischemic cardiomyopathy and cardiogenic shock.
We report here a successful case of recovery from cardiogenic shock resulting from ischemic cardiomyopathy, treated by using a left ventricular assist device (LVAD). The LVAD was successfully explanted at the time of simultaneous coronary artery bypass grafting and left ventricular restoration after recovery from end-organ dysfunction by LVAD support. (Ann Thorac Cardiovasc Surg 2010; 16: 52-54).
PMID: 20190712 [PubMed - in process] (Source: Annals of Thoracic and Cardiovascular Surgery)...
POSTED 03/02/2010 at 01:36 PM --
|
The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative
Conclusion
In contrast to patients with stable CAD, in the acute setting, the relationship between presenting HR and in-hospital cardiovascular outcomes has a ‘J-shaped’ curve (higher event rates at very low and high HRs). These associations should be considered in ACS prognostic models. (Source: European Heart Journal)...
POSTED 03/01/2010 at 02:05 AM --
|
Resolution of ST-segment depression: a new prognostic marker in ST-segment elevation myocardial infarction
Conclusion
When ST depression is present in STEMI patients undergoing primary PCI, STD-R<50% provides independent prognostic value that is incremental to STE-R. (Source: European Heart Journal)...
POSTED 03/01/2010 at 02:05 AM --
|
Predictors and in-hospital outcomes of cardiogenic shock on admission in patients with acute coronary syndromes admitted to hospitals without on-site invasive facilities.
Conclusions: CS on admission is an important determinant of treatment strategy selection and is associated with unfavorable prognosis of ACS patients admitted to hospitals without on-site invasive facilities.
PMID: 20201656 [PubMed - in process] (Source: Acute Cardiac Care)...
POSTED 02/28/2010 at 06:00 PM --
|
Current and future perspectives in cardiogenic shock, reperfusion strategies and hemodynamic inotropic support for acute heart failure.
Authors: Beyar R
PMID: 20201655 [PubMed - in process] (Source: Acute Cardiac Care)...
POSTED 02/28/2010 at 06:00 PM --
|
Percutaneous Coronary Intervention or Coronary Artery Bypass Surgery for Cardiogenic Shock and Multivessel Coronary Artery Disease?
Post STEMI revascularization strategies are examined to find the optimal path for those with multi-vessel disease and cardiogenic shock American Heart Journal (Source: Medscape Today Headlines)...
POSTED 02/26/2010 at 06:04 AM --
|
Technique for Left Ventricular Apical Cannulation for Short-Term Mechanical Circulatory Support [HOW TO DO IT]
We describe a simple and reliable technique for left ventricular apical cannulation for this device, which also facilitates decannulation without the use of cardiopulmonary bypass. (Source: The Annals of Thoracic Surgery)...
POSTED 02/23/2010 at 04:46 PM --
|
Haemodynamic effects of acute intravenous metoprolol in apical ballooning syndrome with dynamic left ventricular outflow tract obstruction
We present a case of apical ballooning syndrome complicated by dynamic LVOTO, treated with metoprolol. (Source: European Journal of Heart Failure)...
POSTED 02/15/2010 at 08:51 AM --
|
Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure
Conclusion
Early and late mortality differ between de novo AHF and ADCHF and between clinical classes of AHF. EHFS II identifies clinical risk markers and demonstrates the importance of a thorough characterization of AHF populations according to history and clinical presentation. (Source: European Journal of Heart Failure)...
POSTED 02/15/2010 at 08:51 AM --
|
Right ventricular dysfunction is an independent predictor for mortality in ST-elevation myocardial infarction patients presenting with cardiogenic shock on admission
Conclusion
In STEMI patients presenting with CS on admission and treated with primary PCI, RV dysfunction as assessed by echocardiography is an independent predictor for long-term mortality. (Source: European Journal of Heart Failure)...
POSTED 02/15/2010 at 08:51 AM --
|
Erythropoietins/nandrolone abuse: Myocardial infarction and cardiogenic shock: case report
(Source: Reactions)...
POSTED 02/15/2010 at 08:06 AM --
|
Percutaneous assist devices vs. intra-aortic balloon pump for cardiogenic shock: evidence under construction vs. expert opinion
(Source: European Heart Journal)...
POSTED 02/14/2010 at 02:06 AM --
|
Percutaneous assist devices vs. intra-aortic balloon pump for cardiogenic shock: evidence under construction vs. expert opinion: reply
(Source: European Heart Journal)...
POSTED 02/14/2010 at 02:06 AM --
|
Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock
(Source: British Journal of Anaesthesia)...
POSTED 02/11/2010 at 10:36 AM --
|
Outcomes in Diabetic Versus Nondiabetic Patients Who Present With Acute Myocardial Infarction and Are Treated With Drug-Eluting Stents
In conclusion, after correction for co-morbid conditions, no difference was seen in the 1-year MACE or death rates between those with and without DM who presented with acute myocardial infarction and were treated with drug-eluting stents. (Source: The American Journal of Cardiology)...
POSTED 02/07/2010 at 06:00 PM --
|
